Project Details
| Status | Active |
|---|---|
| Effective start/end date | 11/25/25 → 09/30/29 |
Funding
- Jaeb Center for Health Research Incorporated: $36,717.99
WAVE T1D: A Randomized Phase I/II Trial of Low Dose Anti-thymocyte Globulin (ATG) with Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (WAVE T1D)
- Quattrin, Teresa (PI)
Project: Research